 |
 |
apologies for cross postings We are designing a part-time MSc in Experimental Medicine at Oxford University and would like to ask for your comments. A brief abstract of the course is below. Please could you let us know if you find this course of interest and if you would attend and/or refer a colleague? Any information you have on the need for this type of training or who would be interested, as well as the structure and content of the course would be much appreciated. Sorry for the late notice, but if you would send your comments by 21 November, it would greatly appreciated. Thank you and best regards, Annette Yang Health Sciences Professional Development Centre Department for Continuing Education Oxford University [log in to unmask] www.conted.ox.ac.uk/cpd *** Programme: MSc in Experimental Medicine Duration: 2 year, taught Mode of Study: part-time, 8 modules (each are 5-day courses in Oxford) spread over 2 years plus a project and dissertation Start Date: Autumn 2007 Who is it for? National and international professional practitioners, including clinicians, scientists, pharmacists and nurses, from the NHS, academia and industry, in the multidisciplinary sciences that contribute to this constantly evolving field of modern molecular medicine who want to obtain a better understanding of cancer, diabetes, cardiac, haematological and infectious disease. Course Content The University of Oxford has designed a part-time MSc in Experimental Medicine that brings together specialists to deliver a stimulating course demonstrating the application of new technologies in rational, mechanism-oriented clinical-trial designs, uniting the fundamental precepts of clinical pharmacology and medical statistics with emergent sciences of molecular biology, pharmacogenetics, and structural genomics. The aim of the MSc programme is to provide students with the necessary training and practical experience to enable them to understand the principles that underpin clinical research, and to enable them to translate that understanding into good clinical practice. This will be important in enhancing the quality of experimental medicine in the institutions to which they belong. Specifically, at the end of the course all successful students will understand the following core principles: - how drugs are developed and marketed - important aspects of drug regulation - pharmaceutical factors that affect drug therapy - pharmacokinetics and drug metabolism - pharmacogenetics - pharmacodynamics (pharmacological actions of drugs) and the principles of pharmacokinetic-pharmacodynamic modelling - adverse drug reactions, drug interactions, and pharmacovigilance - clinical trial design for a range of novel therapeutics (an imaging agents) - laboratory assays used to support trial end-points - application of statistics to medicine - use of non invasive imaging in drug development Optional modules could include: - molecular approaches to gene therapy and immunotherapy - principles of cancer chemotherapy - experimental therapeutics in diabetes and metabolic disorders - drug therapy in psychiatry - drug therapy in cardiovascular medicine - structural genomics and drug discovery ___________________________________________________________ List membership settings and archives: http://www.jiscmail.ac.uk/lists/community-health.html List videoconferencing: http://www.groupintervisual.net/hosting/community-health/ List help via e-mail: [log in to unmask]